BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1548938)

  • 1. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
    Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
    Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Huang ME; Ye YC; Chen SR; Chai JR; Lu JX; Zhao L; Gu LJ; Wang ZY
    Haematol Blood Transfus; 1989; 32():88-96. PubMed ID: 2696695
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
    Degos L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trans-retinoic acid. Treatment by differentiation of acute promyelocytic leukemia].
    Castaigne S
    Soins; 1990; (538-539):24-6. PubMed ID: 2237532
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemia.
    Degos L
    Leukemia; 1992 Nov; 6 Suppl 4():44-6. PubMed ID: 1434831
    [No Abstract]   [Full Text] [Related]  

  • 8. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy.
    Incerpi MH; Miller DA; Posen R; Byrne JD
    Obstet Gynecol; 1997 May; 89(5 Pt 2):826-8. PubMed ID: 9166337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acids in the treatment of acute promyelocytic leukemia.
    Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.
    Barbui T; Finazzi G; Falanga A
    Blood; 1998 May; 91(9):3093-102. PubMed ID: 9558362
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.
    Hashimoto S; Koike T; Tatewaki W; Seki Y; Sato N; Azegami T; Tsukada N; Takahashi H; Kimura H; Ueno M
    Leukemia; 1994 Jul; 8(7):1113-5. PubMed ID: 8035603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation therapy in acute promyelocytic leukemia: European experience.
    Degos L
    J Cell Physiol; 1997 Nov; 173(2):285-7. PubMed ID: 9365538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Co-operative study of all-trans retinoic acid as a differentiation induction therapy of acute promyelocytic leukemia].
    Yamada O; Hatake K; Tanimoto M; Ishiyama T; Ohno R; Shirakawa S; Horiuchi A; Tomonaga M; Ohta K
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1981-9. PubMed ID: 8085849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of telomerase activity and RNA expression in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid.
    Akiyama M; Yamada O; Yanagisawa T; Fujisawa K; Eto Y; Yamada H
    Pediatr Blood Cancer; 2006 Apr; 46(4):506-11. PubMed ID: 15770638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
    White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
    Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life-threatening hepatic toxicity caused by all-trans-retinoic acid in a patient with acute promyelocytic leukaemia.
    Shibata K; Shimamoto Y; Ishibashi S; Tominaga H; Suga K; Yamaguchi M
    Clin Lab Haematol; 1994 Jun; 16(2):191-5. PubMed ID: 7955929
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching from all-trans retinoic acid to arsenic trioxide for newly diagnosed acute promyelocytic leukemia.
    Imagawa J
    Leuk Lymphoma; 2018 Dec; 59(12):3013-3015. PubMed ID: 29616847
    [No Abstract]   [Full Text] [Related]  

  • 19. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome observations of acute promyelocytic leukemia treated with all-trans retinoic acid.
    Wu X; Wang WW; Zhou ZL; Zhu GC; Yang ZC; Ying JS; Zhu Y
    Hematol Pathol; 1992; 6(1):25-9. PubMed ID: 1601819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.